| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18632518 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Kretzschmar A, Wiege T, Al-Batran SE, et al.
Rapid and sustained influence of intravenous zoledronic Acid on course of pain and analgesics consumption in patients with cancer with bone metastases: a multicenter open-label study over 1 year. [Journal Article]
Support Cancer Ther 2007 Sep 1; 4(4):203-10.
Abstract | Full Citation | Find Related Articles | | Berenson JR, Vescio R, Henick K, et al.
A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease. [Clinical Trial, Clinical Trial, Phase I, Journal Article]
Cancer 2001 Jan 1; 91(1):144-54.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Pavlakis N, Stockler M
Bisphosphonates for breast cancer. [Journal Article, Review]
Cochrane Database Syst Rev 2002; (1):CD003474.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ripamonti C, Fagnoni E, Campa T, et al.
Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study. [JOURNAL ARTICLE]
Support Care Cancer 2007 Mar 1.
Abstract | Full Citation | | Cartenì G, Bordonaro R, Giotta F, et al.
Efficacy and safety of zoledronic Acid in patients with breast cancer metastatic to bone: a multicenter clinical trial. [Journal Article]
Oncologist 2006 Jul; 11(7):841-8.
Abstract | Full Citation | Find Related Articles | | Rosen LS, Gordon D, Kaminski M, et al.
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Cancer J 2001 Sep-Oct; 7(5):377-87.
Abstract | Full Citation | Find Related Articles | | Wardley A, Davidson N, Barrett-Lee P, et al.
Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Br J Cancer 2005 May 23; 92(10):1869-76.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Perry CM, Figgitt DP
Zoledronic acid: a review of its use in patients with advanced cancer. [Journal Article, Review]
Drugs 2004; 64(11):1197-211.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Berenson JR, Rosen LS, Howell A, et al.
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Cancer 2001 Apr 1; 91(7):1191-200.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
